Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $17.63 USD
Change Today -0.37 / -2.06%
Volume 184.4K
OSIR On Other Exchanges
Symbol
Exchange
NASDAQ GM
Berlin
As of 8:10 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for osiris therapeutics inc (OSIR)

Year over year, Osiris Therapeutics, Inc. has seen their bottom line shrink from a gain of $41.6M USD to a loss of $1.8M USD despite an increase in revenues from $24.3M USD to $59.9M USD. An increase in the percentage of sales devoted to income tax expenses from -5.45% to 0.32% was a key component in the falling bottom line in the face of rising revenues.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Restated
Dec 31
2012
Restated
Dec 31
2013
Dec 31
2014
4 Year
Trend
Revenues1.37.824.359.9
TOTAL REVENUES1.37.824.359.9
Cost of Goods Sold0.52.66.713.2
GROSS PROFIT0.75.317.746.7
Selling General & Admin Expenses, Total7.25.615.538.1
R&D Expenses4.35.55.06.9
OTHER OPERATING EXPENSES, TOTAL11.511.120.545.0
OPERATING INCOME-10.8-5.8-2.81.7
Other Non-Operating Income (Expenses)0.1--0.0-1.4
EBT, EXCLUDING UNUSUAL ITEMS-10.7-5.8-2.80.3
Gain (Loss) on Sale of Investments--0.00.4-0.4
EBT, INCLUDING UNUSUAL ITEMS-10.7-5.8-2.4-0.1
Income Tax Expense-0.80.0-1.30.2
Earnings from Continuing Operations-9.9-5.7-1.1-0.2
EARNINGS FROM DISCOUNTINUED OPERATIONS24.8-5.342.7-1.5
NET INCOME14.9-11.141.6-1.8
NET INCOME TO COMMON INCLUDING EXTRA ITEMS14.9-11.141.6-1.8
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-9.9-5.7-1.1-0.2
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OSIR:US $17.63 USD -0.37

OSIR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BioTime Inc $2.95 USD -0.07
CryoLife Inc $9.54 USD -0.24
Derma Sciences Inc $5.74 USD -0.09
Vericel Corp $3.17 USD +0.03
Vitrolife AB kr165.50 SEK +2.00
View Industry Companies
 

Industry Analysis

OSIR

Industry Average

Valuation OSIR Industry Range
Price/Earnings 100.0x
Price/Sales 7.6x
Price/Book 7.0x
Price/Cash Flow 154.9x
TEV/Sales 7.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OSIRIS THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.